참고문헌 (45)

1. 1) Luo J, Duggan DJ, Chen Y, Sauvageot J, Ewing CM, Bittner ML, Trent JM, Isaacs WB. Human prostate cancer and benign prostatic hyperplasia: Molecular dissection by gene expression profiling. Cancer Res. , 61 , 4683-4688 (2001). 

2. 10.4103/0970-1591.126900 2) Patel ND, Parsons JK. Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction. Indian. J. Urol. , 30 , 170-176 (2014). 

   상세보기

3. 10.1016/j.jep.2014.09.007 3) Afriyie DK, Asare GA, Bugyei K, Adjei S, Lin JM, Peng J, Hong ZF. Treatment of benign prostatic hyperplasia with Croton membranaceus in an experimental animal model. J. Ethnopharmacol. , 157 , 90-98 (2014). 

   상세보기

4. 10.5173/ceju.2011.02.art5 4) Trumbeckas D, Milonas D, Jievaltas M, Matjosaitis AJ, Kincius M, Grybas A, Kopustinskas V. Importance of prostate volume and urinary flow rate in prediction of bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia. Cent. European J. Urol. , 64 , 75-79 (2011). 

   상세보기

5. 10.1038/ijir.2008.55 5) Roehrborn CG. Pathology of benign prostatic hyperplasia. Int. J. Impot. Res. , 20 (Suppl. 3), S11-S18 (2008). 

   상세보기

6. 10.1097/01.ju.0000139539.94828.29 6) Andriole G, Bruchovsky N, Chung LW, Matsumoto AM, Rittmaster R, Roehrborn C, Russell D, Tindall D. Dihydrotestosterone and the prostate: the scientific rationale for 5α-reductase inhibitors in the treatment of benign prostatic hyperplasia. J. Urol. , 172 , 1399-1403 (2004). 

   상세보기

7. 10.1016/S0090-4295(03)00045-1 7) Carson C III, Rittmaster R. The role of dihydrotestosterone in benign prostatic hyperplasia. Urology , 61 (Suppl. 1), 2-7 (2003). 

   상세보기

8. 10.1210/jcem-41-4-793 8) Horton R, Hsieh P, Barberia J, Pages L, Cosgrove M. Altered blood androgens in elderly men with prostate hyperplasia. J. Clin. Endocrinol. Metab. , 41 , 793-796 (1975). 

   상세보기

9. 10.3109/13685538.2010.550660 9) Liao CH, Li HY, Chung SD, Chiang HS, Yu HJ. Significant association between serum dihydrotestosterone level and prostate volume among Taiwanese men aged 40-79 years. Aging Male , 15 , 28-33 (2012). 

   상세보기

10. 10.2147/ciia.2007.2.1.99 10) Miller J, Tarter TH. Update on the use of dutasteride in the management of benign prostatic hypertrophy. Clin. Interv. Aging , 2 , 99-104 (2007). 

    상세보기

11. 10.4103/0019-5359.40582 11) Kumar VL, Wahane VD. Current status of 5alpha-reductase inhibitors in the treatment of benign hyperplasia of prostate. Indian J. Med. Sci. , 62 , 167-175 (2008). 

    상세보기

12. 10.1517/14728214.11.1.111 12) Bullock TL, Andriole GL Jr. Emerging drug therapies for benign prostatic hyperplasia. Expert Opin. Emerg. Drugs , 11 , 111-123 (2006). 

    상세보기

13. 10.1111/j.1743-6109.2010.02157.x 13) Traish AM, Hassani J, Guay AT, Zitzmann M, Hansen ML. Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients. J. Sex. Med. , 8 , 872-884 (2011). 

    상세보기

14. 10.1248/cpb.59.909 14) Tanaka N, Suto S, Kobayashi J. Veramadines A and B, new steroidal alkaloids from Veratrum maackii var. japonicum . Chem. Pharm. Bull. , 59 , 909-912 (2011). 

    상세보기

15. 15) Tezuka Y, Zhao W, Ishii E, Kadota S. Anti- Helicobacter pylori activity of steroidal alkaloids obtained from three Veratrum plants. J. Tradit. Med. , 16 , 196-200 (1999). 

16. 10.1021/acschemneuro.8b00006 16) Wu Y, Li S, Liu J, Liu X, Ruan W, Lu J, Liu Y, Lawson T, Shimoni O, Lovejoy DB, Walker AK, Cong Y, Shi B. Stilbenes from veratrum maackii regel protect against ethanol-induced DNA damage in mouse cerebellum and cerebral cortex. ACS Chem. Neurosci. , 9 , 1616-1624 (2018). 

    상세보기

17. 10.1039/b609306j 17) Li HJ, Jiang Y, Li P. Chemistry, bioactivity and geographical diversity of steroidal alkaloids from the Liliaceae family. Nat. Prod. Rep. , 23 , 735-752 (2006). 

    상세보기

18. 10.1002/mc.10053 18) Davis JN, Kucuk O, Sarkar FH. Expression of prostate-specific antigen is transcriptionally regulated by genistein in prostate cancer cells. Mol. Carcinog. , 34 , 91-101 (2002). 

    상세보기

19. 10.1007/s11418-011-0609-8 19) Bae JS, Park HS, Park JW, Li SH, Chun YS. Red ginseng and 20(S)-Rg3 control testosterone-induced prostate hyperplasia by deregulating androgen receptor signaling. J. Nat. Med. , 66 , 476-485 (2012). 

    상세보기

20. 10.1016/j.fjs.2014.10.001 20) Lu S-H, Chen C-S. Natural history and epidemiology of benign prostatic hyperplasia. Formosan J. Surg. , 47 , 207-210 (2014). 

    상세보기

21. 10.1021/np500810c 21) Chung KS, Cheon SY, An HJ. Effects of resveratrol on benign prostatic hyperplasia by the regulation of inflammatory and apoptotic proteins. J. Nat. Prod. , 78 , 689-694 (2015). 

    상세보기

22. 10.1016/j.diff.2011.04.006 22) Nicholson TM, Ricke WA. Androgens and estrogens in benign prostatic hyperplasia: past, present and future. Differentiation , 82 , 184-199 (2011). 

    상세보기

23. 10.1038/aja.2009.87 23) Zhang XQ, Huang XF, Mu SJ, An QX, Xia AJ, Chen R, Wu DC. Inhibition of proliferation of prostate cancer cell line, PC-3, in vitro and in vivo using (？)-gossypol. Asian J. Androl. , 12 , 390-399 (2010). 

    상세보기

24. 10.1111/j.1365-2796.2005.01570.x 24) Fadeel B, Orrenius S. Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J. Intern. Med. , 258 , 479-517 (2005). 

    상세보기

25. 10.1002/1097-0045(2000)45:10+<43::AID-PROS9>3.0.CO;2-L 25) Griffiths K, Denis LJ. Exploitable mechanisms for the blockade of androgenic action. Prostate Suppl. , 45 (S10), 43-51 (2000). 

    상세보기

26. 10.1210/jcem.74.3.1371291 26) McConnell JD, Wilson JD, George FW, Geller J, Pappas F, Stoner E. Finasteride, an inhibitor of 5α-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia. J. Clin. Endocrinol. Metab. , 74 , 505-508 (1992). 

    상세보기

27. 10.1056/NEJM199210223271701 27) Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS, Vaughan ED, Pappas F, Taylor A, Binkowitz B, Ng J, The Finasteride Study Group. The effect of finasteride in men with benign prostatic hyperplasia. N. Engl. J. Med. , 327 , 1185-1191 (1992). 

    상세보기

28. 10.1016/j.jep.2007.09.026 28) Sun H, Li TJ, Sun LN, Qiu Y, Huang BB, Yi B, Chen WS. Inhibitory effect of traditional Chinese medicine Zi-Shen Pill on benign prostatic hyperplasia in rats. J. Ethnopharmacol. , 115 , 203-208 (2008). 

    상세보기

29. 10.1248/bpb.b17-00468 29) Wijerathne CUB, Park HS, Jeong HY, Song JW, Moon OS, Seo YW, Won YS, Son HY, Lim JH, Yeon SH, Kwun HJ. Quisqualis indica improves benign prostatic hyperplasia by regulating prostate cell proliferation and apoptosis. Biol. Pharm. Bull. , 40 , 2125-2133 (2017). 

    상세보기

30. 10.2174/138161211795049589 30) Paba S, Frau R, Godar SC, Devoto P, Marrosu F, Bortolato M. Steroid 5α-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders. Curr. Pharm. Des. , 17 , 151-167 (2011). 

    상세보기

31. 10.3892/mmr.2015.3566 31) Zhong X, Lin J, Zhou J, Xu W, Hong Z. Anti-proliferative effects of qianliening capsules on prostatic hyperplasia in vitro and in vivo . Mol. Med. Rep , 12 , 1699-1708 (2015). 

    상세보기

32. 10.25011/cim.v31i1.3136 32) Zhong W, Peng J, He H, Wu D, Han Z, Bi X, Dai Q. Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia. Clin. Invest. Med. , 31 , E8-E15 (2008). 

    

33. 10.1016/j.steroids.2010.12.014 33) Vikram A, Kushwaha S, Jena GB. Relative influence of testosterone and insulin in the regulation of prostatic cell proliferation and growth. Steroids , 76 , 416-423 (2011). 

    상세보기

34. 10.1016/S0046-8177(96)90396-2 34) Kyprianou N, Tu H, Jacobs SC. Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Hum. Pathol. , 27 , 668-675 (1996). 

    상세보기

35. 10.1046/j.1365-2443.1998.00223.x 35) Tsujimoto Y. Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria? Genes Cells , 3 , 697-707 (1998). 

    상세보기

36. 10.1074/jbc.C100107200 36) Kamradt MC, Chen F, Cryns VL. The small heat shock protein αB-crystallin negatively regulates cytochrome c - and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation. J. Biol. Chem. , 276 , 16059-16063 (2001). 

    상세보기

37. 10.1097/01.ju.0000150533.94952.25 37) Vela-Navarrete R, Escribano-Burgos M, Farre AL, Garcia-Cardoso J, Manzarbeitia F, Carrasco C. Serenoa repens treatment modifies Bax/Bcl-2 index expression and caspase-3 activity in prostatic tissue from patients with benign prostatic hyperplasia. J. Urol. , 173 , 507-510 (2005). 

    상세보기

38. 10.1371/journal.pone.0095016 38) Ghezali L, Liagre B, Limami Y, Beneytout J-L, Leger DY. Sonic Hedgehog activation is implicated in diosgenin-induced megakaryocytic differentiation of human erythroleukemia cells. PLOS ONE , 9 , e95016 (2014). 

    상세보기

39. 10.1093/nar/gkx1241 39) Bai F, Liu K, Li H, Wang J, Zhu J, Hao P, Zhu L, Zhang S, Shan L, Ma W, Bode AM, Zhang W, Li H, Dong Z. Veratramine modulates AP-1-dependent gene transcription by directly binding to programmable DNA. Nucleic Acids Res. , 46 , 546-557 (2017). 

    상세보기

40. 10.1128/MCB.19.4.2690 40) Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M. NF-κB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol. Cell. Biol. , 19 , 2690-2698 (1999). 

    상세보기

41. 10.1093/carcin/bgi321 41) Ouyang W, Li J, Ma Q, Huang C. Essential roles of PI-3K/Akt/IKKβ/NF-κB pathway in cyclin D1 induction by arsenite in JB6 Cl41 cells. Carcinogenesis , 27 , 864-873 (2006). 

    상세보기

42. 10.1002/jcb.21976 42) Dahlman JM, Wang J, Bakkar N, Guttridge DC. The RelA/p65 subunit of NF-κB specifically regulates cyclin D1 protein stability: implications for cell cycle withdrawal and skeletal myogenesis. J. Cell. Biochem. , 106 , 42-51 (2009). 

    상세보기

43. 10.1016/j.phymed.2012.05.012 43) Mohan S, Abdelwahab SI, Kamalidehghan B, Syam S, May KS, Harmal NS, Shafifiyaz N, Hadi AH, Hashim NM, Rahmani M, Taha MM, Cheah SC, Zajmi A. Involvement of NF-κB and Bcl2/Bax signaling pathways in the apoptosis of MCF7 cells induced by a xanthone compound Pyranocycloartobiloxanthone A. Phytomedicine , 19 , 1007-1015 (2012). 

    상세보기

44. 10.1038/sj.onc.1204926 44) Catz SD, Johnson JL. Transcriptional regulation of Bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene , 20 , 7342-7351 (2001). 

    상세보기

45. 10.1016/S0163-1047(82)91888-X 45) Nunez AA. Dose-dependent effects of testosterone on feeding and body weight in male rats. Behav. Neural Biol. , 34 , 445-449 (1982). 

    상세보기